BioSpace News Archive

TAE Life Sciences announced the publication of a study in the September 22 issue of the Journal of Medical Physics that assessed whether alpha particles generated through the combination of boron target drugs and proton radiation would generate a reaction that would be sufficient to enhance the biological effectiveness of proton therapy in the treatment of prostate cancer.

Eiger BioPharmaceuticals, Inc. today announced that David Cory , President and CEO, will present a company overview at the 2022 Ladenburg Thalmann Healthcare Conference on Thursday, September 29, 2022 at 1:00 PM ET in New York City. Eiger will also host one-on-one meetings with investors at the conference.

MEI Pharma, Inc. (Nasdaq: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that Christine A. White, M.D., has decided to retire and thus does not intend to stand for reelection at the Company’s fiscal year 2023 annual meeting of stockholders after a seven-year tenure as chair of the board and 12 years total serving as a director.

Imvax, Inc. today announced a poster presentation at the 2022 International Cancer Immunotherapy Conference (CICON) in New York City, NY, from September 28 – October 1, 2022.

Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX) announced today that it has entered into a distribution agreement to market Monkeypox Virus Real-Time PCR Detection Kits with Cosmos Holdings Inc. (Nasdaq: COSM) (“Cosmos”).

enVVeno Medical Corporation today announced that Rob Berman, Chief Executive Officer of enVVeno Medical, will participate in a fireside chat at the Ladenburg Thalmann 2022 Healthcare Conference being held on September 29, 2022.

Gilead Sciences, Inc. today announced a new public-private initiative with the Partnership for Health Advancement in Vietnam (HAIVN), a collaboration between Brigham and Women’s Hospital, Harvard Medical School and Beth Israel Deaconess Medical Center.

Luna Innovations Incorporated, a global leader in advanced fiber optic-based technology, announced a new, $14.2 million contract with its long-standing partner Intuitive Surgical, Inc.

CohBar, Inc. today announced that its Board of Directors (the “Board”) has approved a 1-for-30 reverse stock split of the company’s common stock.

INVO Bioscience, Inc. today announced that Dr. Sue Ellen Carpenter of Bloom Fertility, the Company’s Atlanta-based INVO Center, was named a recipient of the Castle Connolly Top Doctor Award for 2023.